Integra LifeSciences(IART) - 2024 Q2 - Earnings Call Presentation

Total revenue $418 million (exceeded high-end of guidance) Adj. EPS$0.63; down ($0.08) vs Q2'23 • Broad demand for Integra's diverse portfolio of leading brands • Continued successful market uptake of CereLink® monitors and microsensors Q2 2024 Earnings Presentation 2 IART Q2 2024 Earnings Presentation Non-GAAP Financial Measures INTEGRA _ July 29, 2024 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that ...